Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening
ABSTRACT Answer questions and earn CME/CNE Each year, the American Cancer Society publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates, and select issues related to cancer screening. In this issue of the journal, the authors summarize current Am...
Gespeichert in:
| Veröffentlicht in: | CA: a cancer journal for clinicians Jg. 67; H. 2; S. 100 - 121 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Wiley Subscription Services, Inc
01.03.2017
|
| Schlagworte: | |
| ISSN: | 0007-9235, 1542-4863, 1542-4863 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | ABSTRACT
Answer questions and earn CME/CNE
Each year, the American Cancer Society publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates, and select issues related to cancer screening. In this issue of the journal, the authors summarize current American Cancer Society cancer screening guidelines, describe an update of their guideline for using human papillomavirus vaccination for cancer prevention, describe updates in US Preventive Services Task Force recommendations for breast and colorectal cancer screening, discuss interim findings from the UK Collaborative Trial on Ovarian Cancer Screening, and provide the latest data on utilization of cancer screening from the National Health Interview Survey. CA Cancer J Clin 2017;67:100–121. © 2017 American Cancer Society. |
|---|---|
| Bibliographie: | serves as Principal Investigator to two CDC funded ACS cooperative agreements to promote HPV vaccination and is member of the HPV Roundtable. All remaining authors report no conflicts of interest. reports that he will receive partial salary support through this contribution for his efforts as Principal Investigator of the Roundtable. The American Cancer Society (ACS) has received a contribution from AstraZeneca Pharmaceuticals LP, as the founding sponsor of a National Lung Cancer Roundtable to engage key organizations in reducing incidence, morbidity, and mortality from lung cancer through appropriate screening, smoking cessation, and management. Robert A. Smith and DISCLOSURES Stacey A. Fedewa Otis W. Brawley Debbie Saslow are employed by the ACS, which received a grant from Merck, Inc. for intramural research; however, their salary is solely funded through ACS funds. SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
| ISSN: | 0007-9235 1542-4863 1542-4863 |
| DOI: | 10.3322/caac.21392 |